256 related articles for article (PubMed ID: 32620534)
21. The BSCC code of practice--exfoliative cytopathology (excluding gynaecological cytopathology).
Chandra A; Cross P; Denton K; Giles T; Hemming D; Payne C; Wilson A; Wilson P
Cytopathology; 2009 Aug; 20(4):211-23. PubMed ID: 19659955
[TBL] [Abstract][Full Text] [Related]
22. A retrospective analysis of pleural effusion specimens based on the newly proposed International System for Reporting Serous Fluid Cytopathology.
Xu Y; Hu AY; Wang SM; Wang Q; Pan YC; Zhang SH
Diagn Cytopathol; 2021 Sep; 49(9):997-1007. PubMed ID: 34019334
[TBL] [Abstract][Full Text] [Related]
23. Announcement: The International System for Reporting Serous Fluid Cytopathology.
Chandra A; Crothers B; Kurtycz D; Schmitt F
Acta Cytol; 2019; 63(5):349-351. PubMed ID: 31234178
[TBL] [Abstract][Full Text] [Related]
24. Review of the impact of the International System for Serous Fluid Cytopathology.
Mikou P; Pergaris A; Engels M; Chandra A
Cytopathology; 2024 Jan; 35(1):16-22. PubMed ID: 37795809
[TBL] [Abstract][Full Text] [Related]
25. The International System for Reporting Serous Fluid Cytopathology: A Systematic Review and Meta-Analysis of Diagnostic Test Accuracy Studies.
Jamal FE; Vey JA; Proctor T; Ishak A; Schmitt FC; Nikas IP
Adv Anat Pathol; 2024 Jul; 31(4):256-264. PubMed ID: 38695284
[TBL] [Abstract][Full Text] [Related]
26. Role of Ancillary Techniques in Reporting Serous Fluid Cytology - "Redefining Categories, Refining Diagnosis".
Kapoor S; Samanta S; Kaur K
J Cytol; 2024; 41(2):96-104. PubMed ID: 38779601
[TBL] [Abstract][Full Text] [Related]
27. The international system for reporting serous fluid cytopathology: The initial project survey.
VandenBussche CJ; Crothers B; Chandra A; Schmitt F; Kurtycz DFI
Cytopathology; 2023 May; 34(3):191-197. PubMed ID: 36752688
[TBL] [Abstract][Full Text] [Related]
28. Application of the International System for Reporting Serous Fluid Cytopathology in routine reporting of pleural effusion and assessment of the risk of malignancy.
Jha S; Sethy M; Adhya AK
Diagn Cytopathol; 2021 Oct; 49(10):1089-1098. PubMed ID: 34289263
[TBL] [Abstract][Full Text] [Related]
29. Cytologic diagnosis of "atypical" in serous fluid cytopathology. Approach of the international system for reporting serous fluid cytopathology.
Chandra A; Schmitt F
Diagn Cytopathol; 2022 Apr; 50(4):208-211. PubMed ID: 34499418
[TBL] [Abstract][Full Text] [Related]
30. Risk of malignancy assessment of the International System for Reporting Serous Fluid Cytopathology: Experience in a community hospital setting and comparison with other studies.
Sun T; Wang M; Wang H
Cancer Cytopathol; 2022 Dec; 130(12):964-973. PubMed ID: 35994357
[TBL] [Abstract][Full Text] [Related]
31. Optimal fluid volume for detecting malignancy in serous effusions: a single institution experience.
Beg S; Zanettini C; Queiroz L; Marchionni L; Alperstein SA; Siddiqui MT
J Am Soc Cytopathol; 2023; 12(6):415-422. PubMed ID: 37419704
[TBL] [Abstract][Full Text] [Related]
32. Root cause analysis of indeterminate diagnoses in serous fluids cytopathology.
Gokozan HN; Harbhajanka A; Lyden S; Michael CW
Diagn Cytopathol; 2021 May; 49(5):633-639. PubMed ID: 33125186
[TBL] [Abstract][Full Text] [Related]
33. Are we ready to develop a tiered scheme for the effusion cytology? A comprehensive review and analysis of the literature.
Farahani SJ; Baloch Z
Diagn Cytopathol; 2019 Nov; 47(11):1145-1159. PubMed ID: 31301215
[TBL] [Abstract][Full Text] [Related]
34. Application of the International System for Reporting Serous Fluid Cytopathology with Cytohistological Correlation and Risk of Malignancy Assessment.
Pergaris A; Stefanou D; Keramari P; Sousouris S; Kavantzas N; Gogas H; Mikou P
Diagnostics (Basel); 2021 Nov; 11(12):. PubMed ID: 34943460
[TBL] [Abstract][Full Text] [Related]
35. Deciphering Serous Effusions Using the New International System for Reporting Serous Fluid Cytopathology.
Mandava H; Venkata Renuka I; Potti R; Mounica B; Kalla I
Cureus; 2024 May; 16(5):e60042. PubMed ID: 38774462
[TBL] [Abstract][Full Text] [Related]
36. [Serous fluid cytopathology: International system].
Basset C; Collin L; Vielh P; Courtade-Saïdi M;
Ann Pathol; 2023 Mar; 43(2):96-113. PubMed ID: 36907792
[TBL] [Abstract][Full Text] [Related]
37. Comprehensive evaluation of benign and malignant etiologies of different serous effusions with the International System for Reporting Serous Fluid Cytopathology: A multi-institutional study in Taiwan.
Lu CH; Liu CY; Jhuang JY; Chen CC
Cancer Cytopathol; 2024 Mar; 132(3):169-178. PubMed ID: 38062987
[TBL] [Abstract][Full Text] [Related]
38. The Role of Novel Tiered Reporting System in Serous Fluid Cytology and Risk of Malignancy Assessment: A Retrospective Study in a Tertiary Care Center.
Alashetty S; Sadasivan B; Dharmalingam P; Rajagopal N; Kavya L; Pai MM
J Cytol; 2023; 40(3):107-113. PubMed ID: 37745807
[TBL] [Abstract][Full Text] [Related]
39. Approach to Diagnostic Cytopathology of Serous Effusions.
Shidham VB; Layfield LJ
Cytojournal; 2021; 18():32. PubMed ID: 35126610
[TBL] [Abstract][Full Text] [Related]
40. The World Health Organization Reporting System for Pancreaticobiliary Cytopathology.
Pitman MB; Centeno BA; Reid MD; Siddiqui MT; Layfield LJ; Perez-Machado M; Weynand B; Stelow EB; Lozano MD; Fukushima N; Cree IA; Mehrotra R; Schmitt FC; Field AS
Acta Cytol; 2023; 67(3):304-320. PubMed ID: 36516741
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
